As we transition into 2025, several key issues from 2024 will continue to impact the pharmacy benefit landscape, along with a few new developments…
National CooperativeRx’s member-owned, not-for-profit cooperative model provides additional financial benefits for members. This includes 100% pass-through of rebate true-up, retired equity, and excess revenue in the form of patronage dividends.
Over the last several years, there has been a lot of anti-PBM press and hundreds of state and federal legislative proposals to reform PBMs.
National CooperativeRx recognizes the importance of continuously refining and improving our offerings to meet the needs and expectations of our valued members. That is why we have made significant improvements
20 years ago, National CooperativeRx was founded as a member-owned not-for-profit to provide plan sponsors with expertise and purchasing power when working with a pharmacy benefit manager
First launched in 2003, Humira has experienced more than two decades of unprecedented marketplace dominance. A mainstay of treatment for several autoimmune conditions, National CooperativeRx’s members spend more on this drug than any other under the pharmacy benefit.
2024 marks 20 years that National CooperativeRx has been providing expertise and purchasing power to plan sponsors. The Cooperative was founded by forward-looking employers and business groups searching for someone they could trust to navigate working with a pharmacy benefit manager
CVS Caremark (CVSC) recently announced a new formulary strategy where they prefer a lower list price approach over a higher list for higher rebates approach.
Market check pricing improvements for our CVS Caremark Master Contract have been completed. These improvements will automatically take effect January 1, 2024. Market check pricing
As a community, we accomplish more together than we can alone. The support of a community becomes even more important when faced with challenges from
At National CooperativeRx, we conduct an annual member and partner satisfaction survey to assess our performance, the importance of specific National CooperativeRx aspects, and the
Drum roll, please! The final numbers are in, and we are excited to share that National CooperativeRx was able to distribute $6.1 MILLION to our